NDC 0143-9511

Etoposide

Etoposide

Etoposide is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by West-ward Pharmaceuticals Corp. The primary component is Etoposide.

• Product ID: 0143-9511_5ea63f7d-fc26-4a51-a8aa-bdb385562e66
• NDC: 0143-9511
• Product Type: Human Prescription Drug
• Proprietary Name: Etoposide
• Generic Name: Etoposide
• Dosage Form: Injection
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 1997-02-01
• Marketing Category: ANDA / ANDA
• Application Number: ANDA074290
• Labeler Name: West-Ward Pharmaceuticals Corp
• Substance Name: ETOPOSIDE
• Active Ingredient Strength: 20 mg/mL
• Pharm Classes: Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2019-12-31

Packaging

NDC 0143-9511-01

1 VIAL in 1 BOX, UNIT-DOSE (0143-9511-01) > 25 mL in 1 VIAL

• Marketing Start Date: 2017-10-23
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0143-9511-01 [00143951101]

Etoposide INJECTION

• Marketing Category: ANDA
• Application Number: ANDA074290
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2017-10-23

Drug Details

Active Ingredients

Ingredient	Strength
ETOPOSIDE	20 mg/mL

OpenFDA Data

• SPL SET ID: 6dfedeff-a807-4405-a482-2f7109ad31c9
• Manufacturer:
  • West-Ward Pharmaceuticals Corp
• UNII:
  • 6PLQ3CP4P3
• RxNorm Concept Unique ID - RxCUI:
  • 310248

Pharmacological Class

• Topoisomerase Inhibitor [EPC]
• Topoisomerase Inhibitors [MoA]

NDC Crossover Matching brand name "Etoposide" or generic name "Etoposide"

NDC	Brand Name	Generic Name
0143-9376	Etoposide	Etoposide
0143-9510	Etoposide	Etoposide
0143-9511	Etoposide	Etoposide
0143-9512	Etoposide	Etoposide
0378-3266	Etoposide	etoposide
16729-114	Etoposide	Etoposide
16729-262	Etoposide	Etoposide
63323-104	Etoposide	ETOPOSIDE
68001-265	Etoposide	Etoposide
0703-5653	Toposar	Etoposide
0703-5656	Toposar	Etoposide
0703-5657	Toposar	Etoposide